For single-cell RNAseq: I have data that were mutliplexed using HTO antibodies.…
- User
For single-cell RNAseq: I have data that were mutliplexed using HTO antibodies. Unfortunately (as expected, though), not all cells got tagged, so what is a proper strategy: normalize using all cells and then exclude untagged, or exclude untagged and then normalize? Please discuss both approaches
Assistant
When dealing with multiplexed single-cell RNA-seq data with untagged cells (negative for HTOs), the recommended strategy is to exclude untagged cells first, then normalize the remaining tagged cells. Below, I discuss both approaches, their implications, and rationale:
Approach 1: Normalize Using All Cells, Then Exclude Untagged
- Steps:
- Apply normalization (e.g., log-normalization, SCTransform, or library size correction) to the entire dataset (tagged + untagged cells).
- Remove untagged cells (and doublets) post-normalization.
- Pros:
- Preserves technical/biological variation from all cells during normalization.
- Avoids batch effects if untagged cells are systematically different (e.g., due to sample-specific biases).
- Cons:
- Skews normalization: Untagged cells often represent low-quality cells (e.g., damaged, empty droplets, or apoptotic cells) with aberrant RNA content. Including them:
- Distorts library size estimates (e.g., median-of-ratios in SCTransform).
- Biases gene expression scaling (e.g., untagged cells may inflate/deflate mean expression).
- Amplifies noise: Untagged cells dilute signal from biologically relevant cells, reducing resolution in downstream analysis (e.g., PCA, clustering).
- Wastes resources: Normalization computations on cells destined for removal are inefficient.
- Skews normalization: Untagged cells often represent low-quality cells (e.g., damaged, empty droplets, or apoptotic cells) with aberrant RNA content. Including them:
Approach 2: Exclude Untagged Cells First, Then Normalize
- Steps:
- Identify and remove untagged cells (and doublets) using HTO demultiplexing (e.g., with
Seurat::HTODemux,MULTIseqDemux, orhashedDrops). - Apply normalization only to tagged cells.
- Identify and remove untagged cells (and doublets) using HTO demultiplexing (e.g., with
- Pros:
- Focused normalization: Normalization is based solely on high-quality, sample-specific cells.
- Avoids contamination from low-quality/non-biological signals.
- Preserves sample-specific differences (e.g., biological variation between multiplexed samples).
- Downstream accuracy: Improves clustering, DE analysis, and visualization by reducing noise.
- Standard practice: Supported by tools like Seurat and best-practice workflows (e.g., Satija Lab).
- Focused normalization: Normalization is based solely on high-quality, sample-specific cells.
- Cons:
- If untagged cells include rare biological populations (e.g., unannotated cell types), they are lost.
- Risk of over-filtering if demultiplexing is too stringent (mitigated by adjusting HTO thresholds).
Key Considerations & Recommendations
-
Untagged Cells Are Typically Noise:
- Most untagged cells arise from failed HTO binding, empty droplets, or dead cells. Retaining them adds technical artifacts.
- Exception: If you suspect untagged cells include viable populations (e.g., in rare cell-type studies), validate their quality (mitochondrial %, gene counts) before deciding.
-
Demultiplexing First Streamlines Workflow:
- Demultiplexing (e.g., with Seurat’s
HTODemux) should precede gene expression analysis. This:- Separates multiplexed samples.
- Filters low-confidence cells.
- Only tagged singlets should proceed to normalization.
- Demultiplexing (e.g., with Seurat’s
-
Normalization Method Matters:
- Log-normalization: Excluding untagged cells prevents distortion of scaling factors (e.g.,
scale.factorinNormalizeData). - SCTransform: More sensitive to library size biases; untagged cells with low RNA content corrupt variance stabilization.
- Log-normalization: Excluding untagged cells prevents distortion of scaling factors (e.g.,
-
Practical Workflow Outline (using Seurat):
# Step 1: Create Seurat object with RNA + HTO assays seurat_obj <- CreateSeuratObject(counts = rna_counts) seurat_obj[["HTO"]] <- CreateAssayObject(counts = hto_counts) # Step 2: Demultiplex (exclude negatives/doublets) seurat_obj <- NormalizeData(seurat_obj, assay = "HTO", normalization.method = "CLR") seurat_obj <- HTODemux(seurat_obj, assay = "HTO", positive.quantile = 0.99) seurat_obj <- subset(seurat_obj, subset = HTO_classification.global == "Singlet") # Step 3: Normalize RNA data (only singlets) seurat_obj <- NormalizeData(seurat_obj) # or SCTransform()
Conclusion
Exclude untagged cells before normalization in almost all cases. This approach:
- Targets normalization to biologically relevant cells.
- Minimizes artifacts from low-quality/background signals.
- Aligns with established scRNA-seq best practices.
Exception: Only retain untagged cells if they pass rigorous QC and are biologically relevant (e.g., validated via marker genes). Even then, analyze them separately from tagged cells.
- Steps:
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.